Eli Lilly Offers Obesity Drug Directly to Consumers
Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.
Stay updated with breaking news from New Medication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.
Tirzepatide, a diabetes medication, is approved for weight loss management by FDA and is found to be very beneficial when combined with diet and exercise.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
This Study and Others Presented at the EULAR European Congress of Rheumatology 2023 CreakyJoints®, the digital, international patient community for people with all forms of arthritis and part of